Mesalamine Capsule, Extended Release
Product Images NDC 59651-397

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 59651-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.375 g (120 Capsules Bottle))

Label for Mesalamine Extended-Release Capsules, USP 0.375 g, containing 120 capsules. Distributed by Aurobindo Pharma USA, Inc. The label includes dosage details, storage instructions, and manufacturing information stating the product is made in India. The color guide and printing specifications are also visible.*

FDA Label Image

Structure (Mesalamine Str)

Chemical structure of mesalamine, showing a benzene ring with amino, hydroxyl, and carboxyl functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.